These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4215835)

  • 21. Reactions of nascent C567 (reactive lysis).
    Goldman JN
    Transplant Proc; 1974 Mar; 6(1):21-5. PubMed ID: 4817055
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies in vivo of cobra factor and murine C3.
    Pepys MB
    Immunology; 1975 Feb; 28(2):369-77. PubMed ID: 804439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on type specific immunity to the whole venom and a fraction of Agkistrodon rhodostoma.
    Lewis LJ; Martin DL; Buckner S; Finley R; Lazer L; Fedor EJ
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):649-56. PubMed ID: 4109789
    [No Abstract]   [Full Text] [Related]  

  • 25. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HAEMOLYTIC ACTION OF COBRA VENOM LECITHINASE-A IN THE PRESENCE OF WHOLE GUINEA-PIG SERUM OR LECITHIN.
    VAN OSSC ; GOETZE O
    Z Immunitats Allergieforsch; 1963 May; 125():75-9. PubMed ID: 14048618
    [No Abstract]   [Full Text] [Related]  

  • 27. The antibacterial efficiencies of ovine IgA, IgM, and IgG.
    Knop JG; Rowley D
    J Infect Dis; 1974 Oct; 130(4):368-73. PubMed ID: 4216609
    [No Abstract]   [Full Text] [Related]  

  • 28. Cobra venom-induced hemolysis. Activity levels in sera of patients with neoplastic and other diseases.
    Brai M; Osler AG
    J Exp Med; 1972 Oct; 136(4):950-5. PubMed ID: 5066513
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement-dependent anaphylactic reactions.
    Tom BH; Raffel S
    Infect Immun; 1975 Jun; 11(6):1284-90. PubMed ID: 1140848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-dependent lymphoid cell-mediated cytotoxicity: role of complement.
    Van Boxel JA; Paul WE; Green I; Frank MM
    J Immunol; 1974 Jan; 112(1):398-403. PubMed ID: 4812178
    [No Abstract]   [Full Text] [Related]  

  • 32. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective deficiency of the second component of complement in a patient with anaphylactoid purpura.
    Gelfand EW; Clarkson JE; Minta JO
    Clin Immunol Immunopathol; 1975 Jul; 4(2):269-76. PubMed ID: 1095265
    [No Abstract]   [Full Text] [Related]  

  • 34. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
    Miyama A; Kato T; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes.
    Phillips JK; Snyderman R; Mergenhagen SE
    J Immunol; 1972 Aug; 109(2):334-41. PubMed ID: 4114826
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigenic relationship between the fourth component of human and guinea pig complement.
    Ohanian SH; Borsos T
    J Immunol; 1975 Jan; 114(1 Pt 1):161-4. PubMed ID: 46239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors.
    Schultz DR; Miller KD
    Infect Immun; 1974 Jul; 10(1):128-35. PubMed ID: 4210424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral immunostimulation. IV. Role of complement.
    Shearer WT; Atkinson JP; Frank MM; Parker CW
    J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cobra complement system: I. The alternative pathway of activation.
    Vogel CW; Müller-Eberhard HJ
    Dev Comp Immunol; 1985; 9(2):311-25. PubMed ID: 3894085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structure and function of the third component of guinea pig complement. I. The effect of chemical reagents on immune hemolysis and immune adherence reactivity.
    Okuda T
    Immunochemistry; 1973 Jun; 10(6):373-9. PubMed ID: 4738908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.